INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-693602906-trial site selection]( "Community Connections: Leveraging Localized Patient Access In Clinical Trials")
Community Connections: Leveraging Localized Patient Access In Clinical TrialsThis roundtable brought together several experts to discuss how expanding community-based research can transform clinical trial recruitment and representation.
-
![GettyImages-2210195887-tablet-phone-recruitment]( "How To Reduce Eligibility Risk And Prevent Protocol Deviations")
How To Reduce Eligibility Risk And Prevent Protocol DeviationsEliminate enrollment-based protocol deviations and align with the latest FDA guidance by implementing a centralized, technology-enabled eligibility review to safeguard trial integrity.
-
![obesity-clinical-trials-GettyImages-1454588173]( "Overcoming Challenges In Obesity Trials")
Overcoming Challenges In Obesity TrialsObesity trials face high dropout rates due to long durations and complex requirements. Overcome these hurdles with personalized engagement, expert lifestyle support, and proactive patient care.
-
![GettyImages-2167387195-computer-graphs-hand-team-digital]( "Outgrowing Excel: Implementing RTSM In A Live Phase I Trial")
Outgrowing Excel: Implementing RTSM In A Live Phase I TrialLearn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.
-
Early Immune Profiling With In Vivo, In Vitro, And Ex Vivo Systems10/7/2025
Modern biologics increasingly interact with the immune system. While these innovations enable transformative therapies, they can also provoke acute immune activation during first-in-human (FIH) trials.
-
Strategic ADC Development In A Shifting Regulatory Landscape8/28/2026
As ADC development grows more complex, sponsors must align safety, dose optimization, global trial design, regulatory strategy and CMC readiness early to reduce risk and accelerate approval.
-
Beyond Automation: Transforming Clinical Trial Delivery Through Structured Information10/23/2026
Study build delays stem less from slow tasks than from protocol intent being reinterpreted at every handoff. Treating the protocol as structured, reusable information changes where AI and expertise belong.
-
The Path Forward In Oncology Trials9/10/2025
A comprehensive site support model is crucial for navigating the complexities of modern oncology trials and accelerating drug development.
-
How Pharmaceutical Companies Can Effectively Engage With PAOs2/11/2025
Experts explain the role of Patient Advocacy Organizations (PAOs), tips for pharmaceutical companies and PAOs to forge strong relationships, and techniques to integrate patient perspectives.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![Rare Disease Clinical Trials – The Importance Of Rigorous Study Designs]( "Get Novel Infectious Disease Vaccines, Therapies To Market Faster")
Infectious diseases are a threat to global health and way of life everywhere. Time is of the essence when it comes to developing safe and effective infectious disease vaccines and treatments.
-
![GettyImages-1498418424-australia-sydney]( "Why Australia Is The Best Place In The World For Early Phase Studies")
The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.
-
![Cloud computing digita-GettyImages-2161057424]( "Unify Workflows And Accelerate Execution From Protocol To Submission")
Explore a platform that benefits the entire global clinical trial ecosystem by reducing complexity and operational costs while maintaining the highest standards of data security and subject privacy.
-
![Business people talking-GettyImages-1362264935]( "A Hands-On Approach To End-To-End Rater Services")
If rater quality is a risk your study can't afford to take, now is the time to evaluate whether your current approach has the structure to support it.
-
![GettyImages-1358151834 ROI]( "Driving Efficiency And ROI In Clinical Trials")
Integrate sensors into your study to evaluate digital endpoints with a comprehensive solution that accelerates drug development, reduces patient sample sizes, cuts costs, and improves patient insights.
